US Stocks
/
Prime Medicine, Inc. Share Price
Prime Medicine, Inc. Share Price

Prime Medicine, Inc. Share Price

NASDAQ: PRME | Small Cap
$4.00
+$0.39 (10.82%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Prime Medicine, Inc. Stock Performance

Open
$3.59
Prev. Close
$3.60
Circuit Range
N/A
Day Range
$3.54 - $4.14
Year Range
$2.67 - $6.65
Volume
4,85,605
Average Traded
$3.97

Prime Medicine, Inc. Share Price Today

As of 11 October 2026, Prime Medicine, Inc.'s share price is $4.00. The stock opened at $3.59, compared to its previous close of $3.60. During today's trading session, Prime Medicine, Inc.'s share price traded between $3.54 and $4.14, with an average price of $3.84. Over the past 52 weeks, the stock has recorded a high of $6.65 and a low of $2.67. In terms of performance, Prime Medicine, Inc.'s share price has risen by 12.85% over the last six months and is down 19.13% on a year-on-year basis.

Prime Medicine, Inc. Share Price Chart

$3.54$4.14
L
Show Current Price
H

Prime Medicine, Inc. Stock Fundamentals & Key Indicators

Market Cap
$594.29M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.04
Revenue (TTM)
$4.63B
Return On Equity (TTM)
-471.98%
Profit Margin
-4344.28%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
16.75%

Prime Medicine, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$1.23$0.84$0.86$1.15
Net Profit-$50.58-$46.08-$49.12-$42.11
Net Profit Margin-4112.20%-5485.71%-5711.63%-3661.74%
Income ChangeN/A8.90%-6.60%14.27%

Prime Medicine, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$2.98$4.63
Net Profit-$142.01-$198.13-$195.88-$201.14
Net Profit MarginN/AN/A-6573.15%-4344.28%
Income ChangeN/A-39.52%1.14%-2.69%

About Prime Medicine, Inc.

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

Prime Medicine, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$3.04
$4.00
+30.34%
Sep 2026
$3.55
$3.06
-16.03%
Aug 2026
$2.89
$3.65
+25.21%
Jul 2026
$3.70
$2.92
-20.79%
Jun 2026
$3.52
$3.68
+3.37%
May 2026
$3.46
$3.56
+0.56%
Apr 2026
$3.56
$3.54
+1.72%
Mar 2026
$4.48
$3.48
-24.84%
Feb 2026
$3.76
$4.63
+21.20%
Jan 2026
$3.50
$3.82
+10.72%
Dec 2025
$3.73
$3.45
-9.69%
Nov 2025
$4.92
$3.82
-22.67%

PRME Share Price FAQs

What is Prime Medicine, Inc. share price today?

chevron-up
Prime Medicine, Inc. share price today is $4.00 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Prime Medicine, Inc. stock?

chevron-up
The 52 week high of Prime Medicine, Inc. stock is $6.65, while the 52 week low is $2.67 as of 10 Oct '26.

What is PRME's market capitalisation today?

chevron-up
PRME market capitalisation is $594.29M as of October 11, 2026, at 12:25 am IST.

What is PRME's net income for the last quarter?

chevron-up
PRME's net income for the last quarter is -42.11B USD.

What is the 5 year returns of PRME?

chevron-up
The 5 year returns of PRME is -80.19% as on 10 Oct '26.

What is the high & low stock price of PRME today?

chevron-up
PRME stock price hit a high of $4.14 and low of $3.54 as of 10 Oct '26.

Can I buy PRME shares in India?

chevron-up
Yes. You can buy PRME in India by opening an international trading account.